Stratification according to autoantibody status in systemic sclerosis reveals distinct molecular signatures
Open Access
- 22 October 2024
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 84 (3) , 480-490
Abstract
Objectives Systemic sclerosis (SSc) is a heterogeneous disease, complicating its management. Its complexity and the insufficiency of clinical manifestations alone to delineate homogeneous patient groups further challenge this task. However, autoantibodies could serve as relevant markers for the pathophysiological mechanisms driving the disease. Identifying specific immunological mechanisms based on patients’ serological statuses might facilitate a deeper understanding of the diversity of the disease. Methods A cohort of 206 patients with SSc enrolled in the PRECISESADS cross-sectional study was examined. Patients were stratified based on their anti-centromere (ACA) and anti-SCL70 (SCL70) antibody statuses. Comprehensive omics analyses including transcriptomic, flow cytometric, cytokine and metabolomic data were analysed to characterise the differences between these patient groups. Results Patients with SCL70 antibodies showed severe clinical features such as diffuse cutaneous sclerosis and pulmonary fibrosis and were biologically distinguished by unique transcriptomic profiles. They exhibit a pro-inflammatory and fibrotic signature associated with impaired tissue remodelling and increased carnitine metabolism. Conversely, ACA-positive patients exhibited an immunomodulation and tissue homeostasis signature and increased phospholipid metabolism. Conclusions Patients with SSc display varying biological profiles based on their serological status. The findings highlight the potential utility of serological status as a discriminating factor in disease severity and suggest its relevance in tailoring treatment strategies and future research directions.Keywords
Funding Information
- Innovative Medicines Initiative Joint (115565)
- Agence Nationale de la Recherche (ANR-11-LABX-0016-001)
This publication has 43 references indexed in Scilit:
- Blood Neutrophil Count and Neutrophil‐to‐Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis CohortsArthritis Care & Research, 2022
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune DiseasesArthritis & Rheumatology, 2020
- Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsetsAutoimmunity Reviews, 2020
- Fatty Acid Metabolites Combine with Reduced β Oxidation to Activate Th17 Inflammation in Human Type 2 DiabetesCell Metabolism, 2019
- Altered B lymphocyte homeostasis and functions in systemic sclerosisAutoimmunity Reviews, 2018
- Association of Defective Regulation of Autoreactive Interleukin‐6–Producing Transitional B Lymphocytes With Disease in Patients With Systemic SclerosisArthritis & Rheumatology, 2018
- The role of Fras1/Frem proteins in the structure and function of basement membraneThe International Journal of Biochemistry & Cell Biology, 2011
- Systemic sclerosis and lupus: Points in an interferon‐mediated continuumArthritis & Rheumatism, 2010
- Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cellsArthritis & Rheumatism, 2004
- Cytokeratins in normal lung and lung carcinomasVirchows Archiv B Cell Pathology Including Molecular Pathology, 1984